Answer
In most reported cases of eosinophilic pneumonia associated with Cubicin, patients developed fever, dyspnoea with hypoxic respiratory insufficiency, and diffuse pulmonary infiltrates or organising pneumonia.
Sources for this answer
- Cubicin powder for concentrate for solution for injection or infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 26Document updated
Sources checked